Tempest Therapeutics Inc. diskutieren
Tempest Therapeutics Inc.
WKN: A3CSM8 / Symbol: TPST / Name: Tempest Therapeutics / Aktie / Small Cap /
3,24 €
1,24 %
Tempest Therapeutics, Inc. (NASDAQ: TPST) had its price target lowered by analysts at Piper Sandler from $10.00 to $6.00. They now have an "overweight" rating on the stock.
Ratings data for TPST provided by MarketBeat
Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Tempest Therapeutics, Inc. (NASDAQ: TPST) had its price target raised by analysts at HC Wainwright from $35.00 to $47.00. They now have a "buy" rating on the stock.
Ratings data for TPST provided by MarketBeat
Tempest Therapeutics, Inc. (NASDAQ: TPST) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for TPST provided by MarketBeat
It seems that Tempest Therapeutics Inc. experienced a significant decline in its stock price today, which may have led to concerns among investors backpack battles
Neueste Beiträge
HC_Wainwright in Protagonist Therapeutics Inc diskutieren